All News

RheumNow Podcast square

$30 Billion and Counting (4.29.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports and takes viewer questions this week.

Read Article
SI,sacroiliitis,erosion

Prolonged TNF Inhibitor Use Delays Sacroiliac Progression

d Jack Cush, MD

While tumour necrosis factor inhibitors (TNFi) have been shown to alter/retard X-ray outcomes in peripheral inflammatory arthritis, the inhibitor effects of TNFi on axial skeletal progression in spondylitis has been difficult to prove, owing to difficulties in study design, identifying best cohorts and a presumed slower rate of change in the spine. 

Read Article
US,hip,injx

Intraarticular Steroids in Hip Osteoarthritis - Do They Work?

d Jack Cush, MD

The efficacy of ultrasound guided intra-articular hip injection of corticosteroid in adult hip osteoarthritis (HOA) was shown to be effective when added to conventional current treatment. But was this a clinically meaningful outcome?

Read Article
TNRPSA,0426

PsA Journal Club - Fecal Transplant & H2H IXE vs ADA

d Jack Cush, MD

Playback now available! Watch our Tuesday Nite Rheumatology, held April 26th, 2022, which featured a Journal Club panel discussion  about two important studies.

Read Article
JIA.oligoarticular.jpg

Biologics for JIA? Not So Fast, Say Insurers

d MedPage Today

It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found.

Read Article
Liver,hepatic,red

Arthritis Predicts Hepatic Fibrosis in Hemochromatosis

d Jack Cush, MD

Mayo Clinic Proceedings reports the results of a retrospective, cross-sectional of patients with HFE hemochromatosis showing that advanced hepatic fibrosis is primarily seen in those with arthritis due to HFE hemochromatosis. 

Read Article
Arthritis Predicts Hepatic Fibrosis in Hemochromatosis https://t.co/AHnRkvq2wo https://t.co/zbl3HQRZCX

Links:

Dr. John Cush RheumNow ( View Tweet)
Today the FDA expanded the indications for upadacitinib (Rinvoq) to include ankylosing spondylitis - specifically for adults w/ active ankylosing spondylitis after failing a TNF blockers or other DMARDs. https://t.co/A9QhT98Djj

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of PCP Dx irritable bowel dz; 459 randomised to 8 weeks of oral antispasmodics or diet (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP). Better responses with diet (71% vs 61%; p=0.03). Better adherence w/ diet. https://t.co/gmn45yQmuB https://t.co/8SP5Vfx71z

Links:

Dr. John Cush RheumNow ( View Tweet)
Nature study shows videoconferencing inhibits creativity (idea generation) because it focuses communicators on a screen, which prompts a narrower cognitive focus. Yet, virtual interaction might increase decision quality. https://t.co/0yTEcmtKye https://t.co/ruwOj9qJ9J

Links:

Dr. John Cush RheumNow ( View Tweet)
Pregnancy outcomes in systemic sclerosis (SSc) studied in 154 pregnancies from SSc, SLE, APS, & controls (2008 to 2019). Adverse Preg Outcomes APO significantly higher in SSc vs HC (61% vs 10%) w/ more miscarriages, preeclampsia, SGA & preterm births https://t.co/P3uksmJy6V https://t.co/nTtgwjdGgL

Links:

Dr. John Cush RheumNow ( View Tweet)
Miss this week’s Tuesday Night Rheumatology? We’ve got you covered. https://t.co/TuBeZTWG9d https://t.co/qWWBSXKKSW

Links:

Dr. John Cush RheumNow ( View Tweet)
Perplexing Oligoarthritis, +FHx, But no psoriasis QD Clinic is sponsored by RheumNow's PsA All the Way Campaign in April 2022 https://t.co/ljZ1cStNTy https://t.co/8RMFFWjDEP

Links:

Dr. John Cush RheumNow ( View Tweet)
SLE (n=2428) pts followed for 224,295 Pt-months- Osteonecrosis seen in 122 pts (6.5/1,000 PtYrs). Higher ON risk - African Americans (2x), Male (1.8x), smokers (1.5x). Higher Rates w/ high dose prednisone (not pulse or IM TCA) https://t.co/omU9Z1Z3kU https://t.co/wceGoCcUBV

Links:

Dr. John Cush RheumNow ( View Tweet)
Systematic literature review of studies where steroids were used as initial "Bridge Therapy" in RA patients - included 10 studies, but only 4 RCTs w/ protocolized discontinuation - these showed 22% were still on GC @ 12 mos, 10% @24 mos https://t.co/aRLhptAASe https://t.co/lg4msIyQfc

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: Dr. Ritchlin discusses Future Discovery and Targets. https://t.co/MOQjXWd6tc https://t.co/EQWBnL9jzI

Links:

Dr. John Cush RheumNow ( View Tweet)
Spanish BIOBADASER registry real world performance of secukinumab in 639 pts w/ #PsA & spondyloarthritis (axSpA, AS, NR axSpA) showed imprved Dz activity at 1 yr & maintained or increased 2 & 3 years. Retention rates best when SEC used 1st biologic https://t.co/MAE3BhLlRg

Links:

Dr. John Cush RheumNow ( View Tweet)

Cardiovascular risk (CVR) was assessed in Psoriasis (#PSO) & #PSA in multiracial population in S Brazil using the Framingham Risk Score. Compared to controls PSO & PSA had higher FRS (16.3 & 18 vs 10.6) and also increased with age. highttps://bit.ly/3k7ySi8

Dr. John Cush RheumNow ( View Tweet)

FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv

Links:

Dr. John Cush RheumNow ( View Tweet)

COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD). https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×